Age (y), mean (range) | 56.74 (24–76) | 58.26 (26–76) | 0.64 |
Gender, n (%) | | | >0.99 |
Male | 19 (55.9%) | 19 (55.9%) |
Female | 15 (44.1%) | 15 (44.1%) |
Race, n (%) | | | >0.99 |
Black | 1 (2.9%) | 1 (2.9%) |
White | 33 (97.1%) | 33 (97.1%) |
Insurance, n (%) | | | 0.20 |
Commercial | 4 (11.8%) | 0 (0%) |
Medicare | 12 (35.3%) | 13 (38.2%) |
Medicaid | 2 (5.9%) | 1 (2.9%) |
Managed care | 11 (32.4%) | 10 (29.4%) |
Blue cross | 5 (14.7%) | 10 (29.4%) |
Tobacco use within past 12 mo, n (%) | | | >0.99 |
Yes | 1 (2.9%) | 1 (2.9%) |
No | 33 (97.1%) | 33 (97.1%) |
Fasting blood glucose (mg/dL), mean (range) | 122.48 (92–174) | 128.73 (79–207) | 0.46 |
Surgeries before index operation (count), mean (range) | | | |
Ever | 0.44 (0–10) | 0.24 (0–4) | 0.98 |
90 d Prior | 0.06 (0–2) | 0.03 (0–1) | >0.99 |
Direct cost of operative supplies and implants ($), mean (range) | 7120 (116–26,035) | 6400 (342–17,459) | 0.75 |
Length of hospital stay (h), mean (range) | 86.73 (25–242) | 69.65 (31–151) | 0.10 |
Length of follow-up (mo), mean (range) | 34.84 (3.0–78.44) | 41.42 (1.3–77.69) | 0.21 |
Non-neurosurgical operations 30 d after index operation (count), mean (range) | 0.12 (0–1) | 0.09 (0–1) | 0.70 |